ATS 2019 Virtual Final Program

P86 The Lung-Enriched p53 Mutant V157F Confers a New Protein Interactome Linked to Transcriptional Regulation in Lung Cancer/ J. Barta, T. Stanek, S.B. McMahon, Philadelphia, PA, p.A3953 P87 Increased Expression of 14-3-3 Proteins in Lung Epithelial Cells: A Potential Role in the Development of Lung Cancer/ R. Hamon, C. Coolen, P.N. Reynolds, S.M. Pitson, J. Woodcock, Adelaide, Australia, p.A3954 P88 Targeting the Mechanically-Induced Metabolic Changes in Lung Cancer Cells Decreases Their Metastatic Potential/ C. Lopez-Martinez, L. Amado-Rodríguez, C. Huidobro, C. del Busto, J. Blazquez-Prieto, J. Mayordomo-Colunga, G.M. Albaiceta, I. Lopez-Alonso, Oviedo, Spain, p.A3955 P89 Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC)/ V. Parvathaneni, M. Goyal, V. Gupta, Queens, NY, p.A3956 P90 Adam10 Mediates Malignant Pleural Invasiveness/ D.D. Cataldo, C. Sepult, M. Bellefroid, B. Duysinx, A. Ludwig, A. Noel, Liege, Belgium, p.A3957 Facilitator : C.D. Ochoa, MD, PhD, Dallas, TX P91 Expression and Clinical Significance of Hsa_circ_0001640 in Lung Adenocarcinoma/ H. Han, Y. Feng, G. Shi, Shanghai, China, p.A3958 P92 In Vitro Analysis of Genomic Heterogeneity in Pre-Invasive Lung Cancer/ K. Gowers, H. Lee-Six, K. Yoshida, F. Millar, D. Chandrasekharan, R. Hynds, R. Thakrar, B. Carroll, P. Campbell, S. Janes, London, United Kingdom, p.A3959 P93 Comprehensive Glycomics Study in Chronic Obstructive Pulmonary Disease and Lung Cancer for Biomarker Discovery/ X. Ji, Atlanta, GA, p.A3960 P94 Cigarette Smoke Activates PI3 Kinase Pathway and Downregulates MicroRNA-1 in Non-Small Cell Lung Cancer (NSCLC)/ A. Korde, A. Ramaswami, M.S. Godfrey, S. Anderson, S. Takyar, New Haven, CT, p.A3961 P95 Chronic Antioxidant NAcetylcysteine Treatment Induces Lung Cancer Formation in Mice/ M. Breau, A. Houssaini, L. Lipskaia, A. Pallazo, G. Collin, G. Czibik, S. Abid, E. Born, E. Marcos, A. Attwe, D. Beaulieu, B. Bourachot, D. Bernard, F. Mechta-Grigoriou, S. Adnot, Creteil, France, p.A3962 P96 Targeting Extracellular Heat Shock Protein 90 a to Overcome Resistance to Gefitinib in Non Small Cell Lung Cancer via Epithelial to Mesenchymal Transition/ H. Dong, X. Wan, J. Zhang, C. Ye, W. Zhong, S. Cai, Guangzhou, China, p.A3963 P97 Krüppel-Like Factor 6 Gene Expression Is Regulated by GATA5 Transcription Factor/ B. Chen, J. Wang, L. Shang, J. Solway, Chicago, IL, p.A3964 P98 Relative Levels of NKX2-1 and the Long-Noncoding RNA NKX2-1-AS1 Regulate Expression of Immune Evasion Genes in Lung Cancer/ M.I. Ramirez, G. Millien, S. Krimberg, Z. Wu, F. Romero, R.S. Summer, H. Kathuria, Philadelphia, PA, p.A3965 P99 IGF1R Deficiency Reduces Tumor Implantation and Burden in a Mouse Model of Lung Metastasis/ J.M. García Pichel, S. Pineiro-Hermida, C. Ruiz-Martinez, I.P. Lopez, E. Alfaro-Arnedo, Logrono, Spain, p.A3966 P100 Myokines Exert an Anti-Proliferative Effect on Lung Adenocarcinoma Through a Proposed Mechanism of Decreased EGFR Activity/ M. Zhang, M. Dela Cruz, S. Datta, H. Roy, Boston, MA, p.A3967 P101 Xenographic Model of Malignant Pleural Effusion/ P.F.B. Colares, A.C.A. Santos, M.M.P. Acencio, A.C. Roque, C.S.R. Silva, V.A. Alvarenga, A.G.P. Silva, V.L. Capelozzi, L.R. Teixeira, Sao Paulo, Brazil, p.A3968 BEHAVIORAL THEMATIC POSTER SESSION B69 THORACIC ONCOLOGY: OPTIMIZING DIAGNOSIS AND MANAGEMENT 9:15 a.m. - 4:15 p.m. KBHCCD Area A (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : M.K. Gould, MD, MS, Pasadena, CA P103 Real World Clinical Efficacy of Lung Cancer Screening/ J. Safi, H. Singh, R. Alpizar-Rivas, J. Breeze, P. LaCamera, Boston, MA, p.A3969 P104 Timeliness of Early Stage Lung Cancer Treatment and Implications for Work Flow/ P. Belligund, K. Bally, C. Gurrier, M.R. Al Ajam, Brooklyn, NY, p.A3970 P105 “Stage Shifting”, A Remarkable Clinical Impact of a Structured Early Diagnosis Program in Lung Cancer/ S. Umekawa, P. Hegde, M.A. Fayed, K.L. Bilello, K. Van Gundy, M.W. Peterson, D. Upadhyay, Fresno, CA, p.A3971 P106 Diagnostic Pitfall of Small Sclerosing Pneumocytoma/ Z. Shang, H. Chen, Shanghai, China, p.A3972 P107 A Population-Based Description of Incidence and Familial Clustering of Pulmonary Carcinoid Tumors/ S. Ansari, B. Bixby, A. Iravani, C. Reddy, L.A. Cannon-Albright, Salt Lake City, UT, p.A3973 P108 Characteristics of Hardcore Smokers in Lung Cancer Screening Population in South Korea/ D.W. Park, J.-Y. Jang, H. Lee, T.S. Park, J.-Y. Moon, S.-H. Kim, T.-H. Kim, H.J. Yoon, D.R. Kang, J.W. Sohn, Seoul, Korea, Republic of, p.A3974 P109 Delays During Diagnosis and Management of Lung Cancer in India- A Prospective Observational Study/ A. Garg, A. Mohan, A. Gupta, S. Sahu, C. Choudhari, S. Arora, D. Jain, R. Kumar, A.S. Bhalla, R.M. Pandey, P. Tiwari, S. Mittal, K. Madan, G.C. Khilnani, V. Hadda, R. Guleria, New Delhi, India, p.A3975 ATS 2019 • Dallas, TX MONDAY • MAY 20 189 MONDAY MORNING